Universal Biosensors Inc (UBI) is an in-vitro diagnostic company which develops and designs electrochemical cell technology platform used in various industries including food and drink, healthcare and agriculture. UBI is working with Siemens Healthcare to develop a range of products for the point-of-care coagulation market and will manufacture test strips for these products. The company’s focus on areas including coagulation testing, blood glucose testing and other electromechanical cell-based tests. It manages its research and development, and manufacturing operations through its subsidiaries located in British Columbia, Canada and Melbourne, Australia. UBI is headquartered in Melbourne, Victoria, Australia.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Universal Biosensors Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Universal Biosensors Inc Company Overview
- Universal Biosensors Inc Company Snapshot
- Universal Biosensors Inc Pipeline Products and Ongoing Clinical Trials Overview
- Universal Biosensors Inc - Pipeline Analysis Overview
- Business Description
- Universal Biosensors Inc - Key Facts
- Universal Biosensors Inc - Major Products and Services
- Universal Biosensors Inc Pipeline Products by Development Stage
- Universal Biosensors Inc Pipeline Products Overview
- C-Reactive Protein Test
- C-Reactive Protein Test Product Overview
- Diagnostic Assay - Coagulation
- Diagnostic Assay - Coagulation Product Overview
- DNA/RNA Blood Glucose Test
- DNA/RNA Blood Glucose Test Product Overview
- Fertility Biosensor
- Fertility Biosensor Product Overview
- Handheld POC Coagulation Testing System - Ambulatory Care
- Handheld POC Coagulation Testing System - Ambulatory Care Product Overview
- Immunoassay Test - D-Dimer
- Immunoassay Test - D-Dimer Product Overview
- PT-INR Testing System - Decentralised And Home Use
- PT-INR Testing System - Decentralised And Home Use Product Overview
- SARS-CoV-2 N-Protein Detection Test
- SARS-CoV-2 N-Protein Detection Test Product Overview
- Xprecia Prime
- Xprecia Prime Product Overview
- Universal Biosensors Inc - Key Competitors
- Universal Biosensors Inc - Key Employees
- Universal Biosensors Inc - Key Employee Biographies
- Universal Biosensors Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Universal Biosensors Inc, Recent Developments
- Apr 19, 2022: Tn Antigen: Peter Mac interim development clinical study results
- Oct 11, 2021: UBI receives $2.8M under the R&D Tax incentive rebate
- Sep 20, 2021: UBI extends clinical development trials for Tn Antigen cancer biosensor
- Dec 30, 2020: UBI’s Canadian subsidiary signs deal with Bayer AG
- Jul 16, 2019: Universal Biosensors: Commentary on Q2 2019 appendix 4C cash flow summary
- Jun 26, 2019: Universal Biosensors: Business Update
- Apr 23, 2019: Universal Biosensors: Commentary on Q1 2019 appendix 4C cash flow summary
- Mar 08, 2019: Universal Biosensors announces resignation of CEO Rick Legleiter
- Jan 29, 2019: Universal Biosensors: Commentary on FY 2018
- Dec 20, 2018: Universal Biosensors provides business update
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Universal Biosensors Inc Pipeline Products and Ongoing Clinical Trials Overview
- Universal Biosensors Inc Pipeline Products by Equipment Type
- Universal Biosensors Inc Pipeline Products by Indication
- Universal Biosensors Inc, Key Facts
- Universal Biosensors Inc, Major Products and Services
- Universal Biosensors Inc Number of Pipeline Products by Development Stage
- Universal Biosensors Inc Pipeline Products Summary by Development Stage
- C-Reactive Protein Test - Product Status
- C-Reactive Protein Test - Product Description
- Diagnostic Assay - Coagulation - Product Status
- Diagnostic Assay - Coagulation - Product Description
- DNA/RNA Blood Glucose Test - Product Status
- DNA/RNA Blood Glucose Test - Product Description
- Fertility Biosensor - Product Status
- Fertility Biosensor - Product Description
- Handheld POC Coagulation Testing System - Ambulatory Care - Product Status
- Handheld POC Coagulation Testing System - Ambulatory Care - Product Description
- Immunoassay Test - D-Dimer - Product Status
- Immunoassay Test - D-Dimer - Product Description
- PT-INR Testing System - Decentralised And Home Use - Product Status
- PT-INR Testing System - Decentralised And Home Use - Product Description
- SARS-CoV-2 N-Protein Detection Test - Product Status
- SARS-CoV-2 N-Protein Detection Test - Product Description
- Xprecia Prime - Product Status
- Xprecia Prime - Product Description
- Universal Biosensors Inc, Key Employees
- Universal Biosensors Inc, Key Employee Biographies
- Universal Biosensors Inc, Subsidiaries
- Glossary
- Universal Biosensors Inc Pipeline Products by Equipment Type
- Universal Biosensors Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Diagnostica Stago SAS
- Bayer Corp
- Roche Diagnostics International Ltd
- Beckman Coulter Inc
- Alere Inc
- Abbott Point of Care Inc
- Siemens Healthineers AG
